Atalanta Sosnoff Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$46M |
| 2 |
Boston Scientific
BSX
|
+$44.6M |
| 3 |
Cisco
CSCO
|
+$40.5M |
| 4 |
ConocoPhillips
COP
|
+$36.2M |
| 5 |
Adobe
ADBE
|
+$36.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$78.6M |
| 2 |
Macy's
M
|
+$58.8M |
| 3 |
Capital One
COF
|
+$51.8M |
| 4 |
Allstate
ALL
|
+$50.3M |
| 5 |
Ralph Lauren
RL
|
+$41.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.97% |
| 2 | Financials | 17.23% |
| 3 | Communication Services | 16.76% |
| 4 | Technology | 14.62% |
| 5 | Industrials | 9.95% |
Similar funds
Atalanta Sosnoff Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Atalanta Sosnoff Capital held 109 positions worth $3.75B, down 7.4% from $4.05B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Atalanta Sosnoff Capital withdrew a net $320M in Q1 2015, closing 8 positions and reducing 50 holdings. Its most notable exit was Ralph Lauren, an estimated $41.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Financials and Communication Services.
Against the trend, Atalanta Sosnoff Capital opened a new position in Boston Scientific worth $50M.
- Atalanta Sosnoff Capital's largest Q1 2015 buy was Boston Scientific: 2,819,545 shares worth $50M.
- Atalanta Sosnoff Capital added most to Allergan plc in Q1 2015, an estimated $46M increase.
- Atalanta Sosnoff Capital's biggest Q1 2015 reduction was Microsoft, cutting an estimated $78.6M.
- Atalanta Sosnoff Capital fully exited Ralph Lauren in Q1 2015, selling an estimated $41.5M.
- Atalanta Sosnoff Capital's ten largest holdings make up 33% of its $3.75B portfolio in Q1 2015.
- Atalanta Sosnoff Capital opened 13 new positions and closed 8 in Q1 2015.
- Atalanta Sosnoff Capital's portfolio value fell 7.4% quarter-over-quarter to $3.75B.
Based on Atalanta Sosnoff Capital's 13F filing for Q1 2015, filed 9 Apr 2015.